{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:03:28Z","timestamp":1791245008740,"version":"4.1.0"},"reference-count":32,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Outpatient treatments, including targeted therapies, in oncology are on the rise. The implementation of remote patient monitoring (RPM) between therapy sessions has the potential to enhance patient care and therapy outcomes in the future.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This pilot study assessed the feasibility of a new, app-based RPM system (bwHealthApp) by capturing patient-reported outcomes (PROs) and vital parameters using a wrist- or in-ear wearable. The study examined adherence, acceptance, and satisfaction, as well as the differences between the two types of wearables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Outpatients with gastrointestinal cancer receiving systemic therapies were invited to use and evaluate the bwHealthApp system for 1 month. The system was set up as an Android smartphone app to assess electronic PROs (ePROs) and connect to wearables for continuous vital sign measurements. A wrist wearable (Beurer AS99) that measured activity and heart rate or an in-ear wearable (Cosinuss Two) that measured heart rate, oxygen saturation, and temperature was used. The data were synchronized remotely to a web client. Outpatients were randomly assigned to the wrist wearable (n=17) or in-ear wearable (n=14) group. At the beginning, middle, and end of the study, patients (N=31) completed questionnaires on various feasibility aspects. Adherence to ePRO completion; wearable use, acceptance, and satisfaction; wearable data quantity and quality; and differences between the wearables were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean adherence to bwHealthApp including dropouts was 46% (449\/971 days) for ePRO completion and 61% (593\/971 days) for wearable use. The system was most frequently used during everyday activities. More than half of the participants were satisfied with bwHealthApp (18\/30, 60%) and could imagine continued use (21\/30, 70%). Notably, 70% (21\/30) rated the system as easy to use. Participants recorded more than 20 million wearable measures; however, 29% (SD 22%, range 3%-76%) of temperature values and 33% (SD 25%, range 10%-92%) of oxygen saturation values were outside the physiological range. For heart rate, the mean proportion of excluded values was 10% (SD 11%, range 4%-48%; in-ear) and 11% (SD 8%, range 4%-33%; wrist). The frequency of use of the two wearables did not differ significantly (\n                      <jats:italic>t<\/jats:italic>\n                      <jats:sub>29<\/jats:sub>\n                      =1.81;\n                      <jats:italic>P<\/jats:italic>\n                      =.08). The wrist wearable scored significantly better than the in-ear wearable regarding wearing comfort (\n                      <jats:italic>t<\/jats:italic>\n                      <jats:sub>28<\/jats:sub>\n                      =\u221211.17;\n                      <jats:italic>P<\/jats:italic>\n                      =.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This bwHealthApp pilot study demonstrates the feasibility of RPM via a mobile app and wearable devices during outpatient systemic cancer therapy, including targeted therapies. The adherence level was moderate, and patients were generally satisfied with the system, although the wrist wearable received a higher rating. The system\u2019s functionality may be enhanced through the integration of additional wearables. This pilot study serves as a foundational framework for long-term assessments examining RPM and clinical data to improve cancer treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/64184","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:45:26Z","timestamp":1761849926000},"page":"e64184-e64184","source":"Crossref","is-referenced-by-count":5,"title":["An App-Based Remote Patient Monitoring System With Wrist and In-Ear Wearables in Gastrointestinal Oncology: Prospective Feasibility Pilot Study"],"prefix":"10.2196","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9225-4096","authenticated-orcid":false,"given":"Lara","family":"Kohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9657-5403","authenticated-orcid":false,"given":"Veit","family":"Scheble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1866-606X","authenticated-orcid":false,"given":"Philip","family":"Storz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0013-5397","authenticated-orcid":false,"given":"Anita","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7505-0426","authenticated-orcid":false,"given":"Selcan Behiye","family":"Ulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8297-7554","authenticated-orcid":false,"given":"Fee","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9444-0506","authenticated-orcid":false,"given":"Christian","family":"Thies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9916-4608","authenticated-orcid":false,"given":"Nisar","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"issue":"3","key":"R1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/picr.picr_62_21","article-title":"Introduction to real-world evidence studies","volume":"12","author":"Chodankar","journal-title":"Perspect Clin Res"},{"issue":"7","key":"R2","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.cell.2024.02.012","article-title":"Generating and using real-world data: a worthwhile uphill battle","volume":"187","author":"Verkerk","journal-title":"Cell"},{"key":"R3","unstructured":"Database query. German Centre for Cancer Registry Data. Robert Koch Institute; 2022. URL: https:\/\/www.krebsdaten.de\/Krebs\/EN\/Database\/databasequery_step1_node.html [Accessed 01-06-2024]"},{"issue":"10294","key":"R4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","journal-title":"The Lancet"},{"issue":"12","key":"R5","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","journal-title":"Ann Oncol"},{"issue":"9","key":"R6","doi-asserted-by":"publisher","first-page":"31450784","DOI":"10.3390\/jcm8091288","article-title":"Physical activity levels are low in inoperable lung cancer: exploratory analyses from a randomised controlled trial","volume":"8","author":"Edbrooke","journal-title":"J Clin Med"},{"issue":"8","key":"R7","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/ijc.28208","article-title":"Association between physical activity and mortality in colorectal cancer: a meta-analysis of prospective cohort studies","volume":"133","author":"Je","journal-title":"Int J Cancer"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.20.00010","article-title":"Quantified kinematics to evaluate patient chemotherapy risks in clinic","volume":"4","author":"Hasnain","journal-title":"JCO Clin Cancer Inform"},{"issue":"12","key":"R9","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.1007\/s00520-020-05395-z","article-title":"Patient-generated health data collection using a wearable activity tracker in cancer patients\u2014a feasibility study","volume":"28","author":"Miyaji","journal-title":"Support Care Cancer"},{"issue":"4","key":"R10","doi-asserted-by":"publisher","DOI":"10.2196\/22931","article-title":"Remote monitoring of the performance status and burden of symptoms of patients with gastrointestinal cancer via a consumer-based activity tracker: quantitative cohort study","volume":"7","author":"Ghods","journal-title":"JMIR Cancer"},{"issue":"2","key":"R11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/bf03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","journal-title":"Behav Res Methods"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Storz P Wickner S Batt B et al. bwHealthApp: a software system to support personalized medicine by individual monitoring of vital parameters of outpatients. Presented at: 14th International Conference on Health Informatics; Feb 11-13, 2021. [doi: 10.5220\/0010324106130620]","DOI":"10.5220\/0010324106130620"},{"key":"R13","unstructured":"Kothgassner OD Felnhofer A Hauk N Kastenhofer E Gomm J Kryspin-Exner I . TUI: Technology Usage Inventory Manual. Information- and Communication Technology Applications: Research on User-oriented Solutions (ICARUS). 2013. URL: https:\/\/www.researchgate.net\/publication\/259292979_Technology_Usage_Inventory_TUI_Manual [Accessed 20-06-2022]"},{"key":"R14","unstructured":"Kaiser A Hohenstein K Werner S . Fragebogen Digitale Kompetenz (DigiKom). KEB Deutschland. 2021. URL: https:\/\/www.mekofun.de\/wp-content\/uploads\/2021\/05\/DigiKom.pdf [Accessed 30-05-2023]"},{"key":"R15","unstructured":"Vuorikari R Kluzer S Punie Y . DigComp 22: The Digital Competence Framework for Citizens \u2013 With New Examples of Knowledge, Skills and Attitudes. Publications Office of the European Union; 2022. [doi: 10.2760\/115376] ISBN: 978-92-76-48882-8"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.3233\/SHTI230333","article-title":"Implementing remote patient monitoring for patients during systemic cancer therapy","volume":"302","author":"Kohn","journal-title":"Stud Health Technol Inform"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2022.884208","article-title":"Wearable use in an observational study among older adults: adherence, feasibility, and effects of clinicodemographic factors","volume":"4","author":"Paolillo","journal-title":"Front Digit Health"},{"issue":"4","key":"R18","doi-asserted-by":"publisher","first-page":"E758","DOI":"10.1097\/NCC.0000000000000999","article-title":"Remote system for daily symptom monitoring during systemic anticancer treatment: patient acceptance, usability, and compliance","volume":"45","author":"Coolbrandt","journal-title":"Cancer Nurs"},{"issue":"6","key":"R19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.clbc.2019.05.005","article-title":"Fitbit usage in patients with breast cancer undergoing chemotherapy","volume":"19","author":"Dreher","journal-title":"Clin Breast Cancer"},{"issue":"Supplement_2","key":"R20","doi-asserted-by":"publisher","first-page":"ii133","DOI":"10.1093\/neuonc\/noad137.452","article-title":"P22.03.A feasibility of and compliance to electronic patient-reported outcome assessment in the molecular tumor board in (neuro-)oncological patients under targeted therapy (TRACE)","volume":"25","author":"Renovanz","journal-title":"Neuro Oncol"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.17.00152","article-title":"Feasibility of wearable physical activity monitors in patients with cancer","volume":"2","author":"Gupta","journal-title":"JCO Clin Cancer Inform"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1186\/s13102-016-0035-z","article-title":"Cancer patients participating in a lifestyle intervention during chemotherapy greatly over-report their physical activity level: a validation study","volume":"8","author":"Vassbakk-Brovold","journal-title":"BMC Sports Sci Med Rehabil"},{"issue":"8","key":"R23","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/pmrj.12475","article-title":"Cancer patients\u2019 perception of usefulness of wearable exercise trackers","volume":"13","author":"Ng","journal-title":"PM&R"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-015-1168-y","article-title":"Repeat physical activity measurement by accelerometry among colorectal cancer patients\u2014feasibility and minimal number of days of monitoring","volume":"8","author":"Skender","journal-title":"BMC Res Notes"},{"issue":"2","key":"R25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1088\/0967-3334\/35\/2\/111","article-title":"The human ear canal: investigation of its suitability for monitoring photoplethysmographs and arterial oxygen saturation","volume":"35","author":"Budidha","journal-title":"Physiol Meas"},{"issue":"6","key":"R26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1001\/jama.2014.17841","article-title":"Accuracy of smartphone applications and wearable devices for tracking physical activity data","volume":"313","author":"Case","journal-title":"JAMA"},{"issue":"1","key":"R27","doi-asserted-by":"publisher","DOI":"10.2196\/30791","article-title":"Accuracy and acceptability of wrist-wearable activity-tracking devices: systematic review of the literature","volume":"24","author":"Germini","journal-title":"J Med Internet Res"},{"issue":"1","key":"R28","doi-asserted-by":"publisher","DOI":"10.2196\/30863","article-title":"Continuous monitoring of vital signs with wearable sensors during daily life activities: validation study","volume":"6","author":"Haveman","journal-title":"JMIR Form Res"},{"issue":"3","key":"R29","doi-asserted-by":"publisher","DOI":"10.2196\/10828","article-title":"Accuracy of consumer wearable heart rate measurement during an ecologically valid 24-hour period: intraindividual validation study","volume":"7","author":"Nelson","journal-title":"JMIR mHealth uHealth"},{"issue":"4","key":"R30","doi-asserted-by":"publisher","DOI":"10.2196\/14707","article-title":"Accuracy of optical heart rate sensing technology in wearable fitness trackers for young and older adults: validation and comparison study","volume":"8","author":"Chow","journal-title":"JMIR mHealth uHealth"},{"issue":"12","key":"R31","doi-asserted-by":"publisher","DOI":"10.2196\/20214","article-title":"Wearability testing of ambulatory vital sign monitoring devices: prospective observational cohort study","volume":"8","author":"Areia","journal-title":"JMIR mHealth uHealth"},{"issue":"1","key":"R32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/1932296820904947","article-title":"Noninvasive continuous monitoring of vital signs with wearables: fit for medical use?","volume":"15","author":"Jacobsen","journal-title":"J Diabetes Sci Technol"}],"container-title":["JMIR Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cancer.jmir.org\/2025\/1\/e64184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:30:37Z","timestamp":1785537037000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancer.jmir.org\/2025\/1\/e64184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":32,"URL":"https:\/\/doi.org\/10.2196\/64184","relation":{},"ISSN":["2369-1999"],"issn-type":[{"value":"2369-1999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"article-number":"v11i3e64184"}}